Pharmacists' perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands.

Autor: Kaymakci B; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Philbert D; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Hazen ACM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Heringa M; SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands., Kwint HF; SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands., Zwart DLM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van Dijk L; Nivel, Netherlands Institute for Health Services Research, Utrecht, The Netherlands.; Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands., Kälvemark Sporrong S; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Kempen TGH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. t.g.h.kempen@uu.nl.; Department of Pharmacy, Uppsala University, Uppsala, Sweden. t.g.h.kempen@uu.nl.
Jazyk: angličtina
Zdroj: International journal of clinical pharmacy [Int J Clin Pharm] 2024 Dec 01. Date of Electronic Publication: 2024 Dec 01.
DOI: 10.1007/s11096-024-01842-7
Abstrakt: Background: Pharmacist prescribing legislation aims to enhance healthcare quality and accessibility. However, in many countries, like the Netherlands, it has not yet been legally established.
Aim: To investigate pharmacists' perspectives on potential pharmacist prescribing in the Netherlands.
Method: An online survey using a questionnaire that was distributed via e-mail and electronic newsletters to most practicing pharmacists in the Netherlands during October and November 2023. The questionnaire was based on previous literature, further developed during an international conference with pharmacists and piloted with Dutch pharmacists. Agreement with statements about potential prescribing models, settings, preconditions, and perceived benefits and risks was measured using a 4-point Likert scale. Data were analysed descriptively.
Results: In total, 625 participants from community pharmacy (n = 432; 69.1%), hospital pharmacy (n = 149; 23.8%), or other/combined settings (n = 44; 7.0%) completed the questionnaire. Most pharmacists (somewhat) agreed with the introduction of an independent prescribing model with limitations (n = 538; 86.1%) or a model dependent on collaborative agreements with physicians (n = 471; 75.4%). A minority (n = 245; 39.2%) supported independent prescribing with diagnostic authority. The precondition that participants most frequently (somewhat) agreed with was access to health records (n = 607; 97.1%). The most (somewhat) agreed-upon benefits were enhanced professional position of pharmacists (n = 574; 91.8%) and reduced workload for other prescribers (n = 573; 91.7%). Increased workload for pharmacists (n = 495; 79.2%) was the most (somewhat) agreed-upon identified risk.
Conclusion: Pharmacists in the Netherlands are generally supportive of an independent but limited or collaborative pharmacist prescribing model. These findings support further investigations into the potential introduction of pharmacist prescribing legislation.
Competing Interests: Conflicts of interest: LvD received funding from Biogen and TEVA Pharmaceuticals for studies not related to this study.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: